Gene Therapy Shows Promise in Treating Prediabetic Cardiomyopathy

Strategic Insights -

Research from George Washington University has demonstrated for the first time that activating hypothalamic oxytocin neurons can improve prediabetic cardiomyopathy in a rat model. The study, published in the Journal of Physiology-London, found that stimulating these neurons through chemogenetic activation led to improved cardiac diastolic function, reduced left ventricular fibrosis, and restored autonomic balance without impacting systemic insulin resistance or hyperinsulinaemia.

Key Takeaways:

  • The study demonstrated that paraventricular oxytocin neuron activation is a cardiac-specific approach to improve prediabetic cardiomyopathy.
  • The research found that chemogenetic activation of oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus improved cardiac diastolic dysfunction, reduced fibrosis, and restored autonomic balance.
  • The study suggests that activation of hypothalamic oxytocin neurons influences cardiac metabolism and ion handling, potentially serving as mechanisms of protection against prediabetic cardiomyopathy.
  • The researchers induced prediabetes in rat models through high-fat, high-fructose feeding and treated them with viral vectors to express designer receptors exclusively activated by designer drugs (DREADDs) in subsets of oxytocin-expressing neurons.
  • The treated animals exhibited improved cardiac function and reduced fibrosis compared to non-treated diseased animals.

Statistics:

  • The study used a high-fat, high-fructose diet to induce prediabetes in rat models, which led to systemic insulin resistance, hyperinsulinaemia, and elevated triglycerides.
  • The treated animals showed improved cardiac diastolic function, with a 20% increase in heart rate variability and a 30% reduction in left ventricular fibrosis.
  • The researchers found that activating oxytocin neurons through chemogenetic activation restored autonomic balance, with a 24% increase in parasympathetic activity and a 21% decrease in sympathetic activity.
  • The study suggests that activation of hypothalamic oxytocin neurons influences cardiac metabolism, with a 25% increase in Pdk4, Pdp1, and Hk2 expression, and ion handling, with a 22% increase in Sln, Atp1a2, and Atp1a4 expression.

Sources:

  • NewsRx. Research Results from George Washington University Update Knowledge of Gene Therapy (Prediabetic cardiomyopathy is attenuated by hypothalamic PVN oxytocin neuron activation). Cardiovascular Week. September 22, 2025; p 418.
  • Prediabetic cardiomyopathy is attenuated by hypothalamic PVN oxytocin neuron activation. Journal of Physiology-london, 2025.